1.
Elsamany SA, Elemam O, Hassanin F, Algahami A, Alghanmi H, El naghi KAEA. Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients. World J Oncol. Published online August 7, 2025. doi:10.14740/wjon2546